Iterion Therapeutics Competitors and Similar CompaniesClear all
Iterion Therapeutics's competitors and similar companies include ImmuNext and DNAtriX.
 Iterion Therapeutics Iterion Therapeutics is a clinical-stage biotechnology company developing targeted cancer therapeutics. | |||
Founding Date | Founding Date 2014 | Founding Date 2011 | Founding Date 2005 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Houston, US HQ | Locations Lebanon, US HQ Alton, US | Locations Houston, US HQ San Diego, US |
Employees | Employees 17 | Employees 3 | Employees 3 |
Funding | |||
Latest funding round | Latest funding round $ 2.6m (almost 8 years ago) | Latest funding round N/A | Latest funding round $ 15.5m (over 7 years ago) |
Total funding raised | Total funding raised $ 4.4m | Total funding raised N/A | Total funding raised $ 54.2m |
For sources of this data, please see the company profile
View Company Profiles
ImmuNext
HQ
Lebanon, US
Employees
3
ImmuNext is a biotech company that develops immunotherapies
View company
DNAtriX
HQ
Houston, US
Employees
3
DNAtrix is a biotechnology company that provides virus-driven immunotherapies for cancer.
View company